Evidence map›Paper›PMID 31505623›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2019

Etiology of Pediatric Bacterial Meningitis Pre- and Post-PCV13 Introduction Among Children Under 5 Years Old in Lomé, Togo.

Enyonam Tsolenyanu, Rowan E Bancroft, Abdul K Sesay, Madikay Senghore, Mawouto Fiawoo, Djatougbe Akolly, Mawussi A Godonou, Novissi Tsogbale, Segla D Tigossou, Leopold Tientcheu and 10 more

Open access · hybridAbstract read
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 4 pooled it
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 4 syntheses or guidelines pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Molecular Epidemiology ofInternational journal of molecular sciences · 2025
    Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 4 institutions in 5 countries.

Enyonam TsolenyanuDepartment of Paediatrics, Sylvanus Olympio Teaching Hospital, Lomé, Togo.
Rowan E BancroftWorld Health Organization (WHO) Collaborating Centre for New Vaccines Surveillance, Medical Research Council Unit The Gambia at London School of Hygiene & Tropical Medicine, Banjul.
Abdul K SesayWorld Health Organization (WHO) Collaborating Centre for New Vaccines Surveillance, Medical Research Council Unit The Gambia at London School of Hygiene & Tropical Medicine, Banjul.
Madikay SenghoreWorld Health Organization (WHO) Collaborating Centre for New Vaccines Surveillance, Medical Research Council Unit The Gambia at London School of Hygiene & Tropical Medicine, Banjul.
Mawouto FiawooDepartment of Paediatrics, Sylvanus Olympio Teaching Hospital, Lomé, Togo.
Djatougbe AkollyDepartment of Paediatrics, Sylvanus Olympio Teaching Hospital, Lomé, Togo.
Mawussi A GodonouDepartment of Microbiology, Sylvanus Olympio Teaching Hospital, Lomé, Togo.
Novissi TsogbaleDepartment of Microbiology, Sylvanus Olympio Teaching Hospital, Lomé, Togo.
Segla D TigossouDepartment of Microbiology, Sylvanus Olympio Teaching Hospital, Lomé, Togo.
Leopold TientcheuWorld Health Organization (WHO) Collaborating Centre for New Vaccines Surveillance, Medical Research Council Unit The Gambia at London School of Hygiene & Tropical Medicine, Banjul.
Anoumou DagnraDepartment of Microbiology, Sylvanus Olympio Teaching Hospital, Lomé, Togo.
Yawo AtakoumaDepartment of Paediatrics, Sylvanus Olympio Teaching Hospital, Lomé, Togo.
Peter Sylvanus NdowWorld Health Organization (WHO) Collaborating Centre for New Vaccines Surveillance, Medical Research Council Unit The Gambia at London School of Hygiene & Tropical Medicine, Banjul.
Archibald WorwuiWorld Health Organization (WHO) Collaborating Centre for New Vaccines Surveillance, Medical Research Council Unit The Gambia at London School of Hygiene & Tropical Medicine, Banjul.
Dadja E LandohWHO Country Office of Togo, Lomé, Togo.
Jason M MwendaWHO Regional Office for Africa WHO/AFRO, Republic of Congo, Brazzaville.
Joseph N BieyWHO Intercountry Support Team West Africa, Ouagadougou, Burkina Faso.
Bernard NtsamaWHO Intercountry Support Team West Africa, Ouagadougou, Burkina Faso.
Brenda A Kwambana-AdamsWorld Health Organization (WHO) Collaborating Centre for New Vaccines Surveillance, Medical Research Council Unit The Gambia at London School of Hygiene & Tropical Medicine, Banjul.
Martin AntonioWorld Health Organization (WHO) Collaborating Centre for New Vaccines Surveillance, Medical Research Council Unit The Gambia at London School of Hygiene & Tropical Medicine, Banjul.
Centre Hospitalier Universitaire de Tokoin · TGMRC Unit the Gambia · GMUnion Economique et Monétaire Ouest Africaine · BFWorld Health Organization Regional Office for Africa · CG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPediatric bacterial meningitis (PBM) causes severe morbidity and mortality within Togo. Thus, as a member of the World Health Organization coordinated Invasive Bacterial Vaccine Preventable Diseases network, Togo conducts surveillance targeting Streptococcus pneumoniae (pneumococcus), Neisseria meningitidis (meningococcus), and Haemophilus influenzae, at a sentinel hospital within the capital city, Lomé, in the southernmost Maritime region.

methodsCerebrospinal fluid was collected from children <5 years with suspected PBM admitted to the Sylvanus Olympio Teaching Hospital. Phenotypic detection of pneumococcus, meningococcus, and H. influenzae was confirmed through microbiological techniques. Samples were shipped to the Regional Reference Laboratory to corroborate results by species-specific polymerase chain reaction.

resultsOverall, 3644 suspected PBM cases were reported, and 98 cases (2.7%: 98/3644) were confirmed bacterial meningitis. Pneumococcus was responsible for most infections (67.3%: 66/98), followed by H. influenzae (23.5%: 23/98) and meningococcus (9.2%: 9/98). The number of pneumococcal meningitis cases decreased by 88.1% (52/59) postvaccine introduction with 59 cases from July 2010 to June 2014 and 7 cases from July 2014 to June 2016. However, 5 cases caused by nonvaccine serotypes were observed. Fewer PBM cases caused by vaccine serotypes were observed in infants <1 year compared to children 2-5 years.

conclusionsRoutine surveillance showed that PCV13 vaccination is effective in preventing pneumococcal meningitis among children <5 years of age in the Maritime region. This complements the MenAfriVac vaccination against meningococcal serogroup A to prevent meningitis outbreaks in the northern region of Togo. Continued surveillance is vital for estimating the prevalence of PBM, determining vaccine impact, and anticipating epidemics in Togo.

Indexed as

Sentinel SurveillanceChild, PreschoolFemaleHaemophilus influenzaeHospitals, UniversityHumansIncidenceInfantInfant, NewbornMaleMeningitis, BacterialNeisseria meningitidisPneumococcal VaccinesPrevalenceSerogroupStreptococcus pneumoniae13-valent pneumococcal vaccinePneumococcal VaccinesmeningitispediatricPneumococcusTogovaccine impact

Identifiers

PMID31505623
PMCPMC6761369
OpenAlexW2972135885

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.